Related Experiment Videos
Summary
Tumor markers are substances indicating malignancy, though not always specific. This review details Carcinoembryonic antigen structure, alpha-fetoprotein in liver cancer models, and oncogene products.
Area of Science:
- Biochemistry
- Oncology
- Medical Diagnostics
Context:
- Tumor markers are crucial biomarkers for detecting and monitoring cancer.
- Understanding tumor marker characteristics aids in differential diagnosis and prognosis.
- The complexity of tumor markers necessitates focused reviews on key examples.
Purpose:
- To define tumor markers and their role in malignancy.
- To explore the structure and function of specific tumor markers like CEA and AFP.
- To discuss the application of oncogene products as potential tumor markers.
Summary:
- Defines tumor markers as substances altered by malignancy, not necessarily tumor-specific.
- Examines the primary structure of Carcinoembryonic antigen (CEA).
- Details changes in serum alpha-fetoprotein (AFP) during experimental rat hepatoma development.
- Discusses clinical applications of AFP for diagnosing liver cirrhosis and hepatoma.
- Introduces oncogene products as emerging tumor markers.
- Lists available and future tumor markers for reference.
Impact:
- Provides a foundational understanding of tumor markers for researchers and clinicians.
- Highlights the diagnostic and prognostic value of specific biomarkers like AFP.
- Offers a concise overview of key tumor markers and their relevance in cancer research.